Help build business ... from home. Director, Business Development: https://hubs.ly/Q02BQrk20 #pharmajobs #oncology #womeninscience
About us
Precision is the first global precision medicine clinical research services organization, purpose-built to improve the clinical research and development process for new therapeutics. Our novel approach integrates clinical operations excellence, with laboratory expertise, and advanced data sciences to inform every step. This maximizes our clients’ insight into patient biology, delivering more predictable trial outcomes and accelerating clinical development. We apply our expertise to trials at all stages—from early development through approval—with embedded experience in oncology and rare disease. With over 2000 dedicated professionals and 35 offices worldwide, we stand ready to help accelerate life-changing treatments anywhere around the globe.
- Website
-
http://www.precisionformedicine.com
External link for Precision For Medicine
- Industry
- Biotechnology Research
- Company size
- 1,001-5,000 employees
- Headquarters
- Bethesda, MD
- Type
- Privately Held
- Specialties
- Global Clinical Trial Services, Specialty Lab Services, Translational Science, Clinical Data Management, Biostatistics, Biomarker Strategies, Sample Sourcing and Storage, Immune Monitoring, IVD Development, CDx Development, Market Access, IVD CRO, Regulatory Strategy and Submission, and Contract Research Organization
Locations
-
Primary
Get directions
2 Bethesda Metro Center
Suite 850
Bethesda, MD 20814, US
-
Get directions
8425 Progress Drive
Fredrick, MD 21701, US
-
Get directions
55 Cambridge Parkway
Ste 300E
Cambridge, MA 02142, US
Employees at Precision For Medicine
Updates
-
News to know in this month's Precision Pipeline. Get expert insights on the 2024 cell therapy trial landscape, the rise of precision medicine in pediatrics and more. View the Precision Pipeline newsletter. https://hubs.ly/Q02BKq6_0
-
-
Don’t let regulatory hurdles slow you down when navigating site activation under EU CTR. Here are practical tips to streamline your process, pitfalls to avoid, and strategies to ensure compliance: https://hubs.ly/Q02BB3gT0 #clinicaltrials #clinicalresearch #drugdevelopment
-
-
Regulatory and startup specialists drive the seamless launch and execution of clinical trials. Their expertise is the key to faster, compliant, and efficient trial start-ups. Explore their critical role and how they can accelerate your journey to groundbreaking research: https://hubs.ly/Q02BkS4G0 #clinicaltrials #clinicalresearch #drugdevelopment
-
-
Meet the Precision team at #DIA2024 next week! Stop by Booth 1600 to speak with Stephen Boccardo, Nathan Becker, Amanda Knapp and Ana Magalhaes or reach out directly to schedule time to speak. https://hubs.ly/Q02BkSpf0
-
-
They literally wrote the book on gene therapy! Free registration for tomorrow's webinar on advancements in gene therapy with Precision's Kennon Daniels and co-authors of the recently published book "Drug Development for Gene Therapy: Translational Biomarkers, Bioanalysis, and Companion Diagnostics." REGISTER HERE: https://hubs.ly/Q02B4sqQ0 #genetherapy #precisionmedicine #biomarkers
-
-
Join Precision's Kennon Daniels, Ph.D. and co-authors of the recently published book "Drug Development for Gene Therapy: Translational Biomarkers, Bioanalysis, and Companion Diagnostics" for a panel discussion of biomarkers for AAV gene therapy, detection and quantification of genome editing events in preclinical and clinical studies, and companion diagnostics for AAV gene therapy. Tuesday, June 11 at 12:00PM ET, 9:00AM PT Register here: https://lnkd.in/e8CMty-C #genetherapy #precisionmedicine
-
-
The FDA’s recent draft guidance on broadening eligibility criteria in cancer clinical trials marks a pivotal shift towards inclusivity and represents a significant stride in oncology research. This move isn’t just about expanding access; it’s about enhancing the relevance and applicability of trial results to the real-world patient population. Explore the potential impact of this change on patients who may benefit from access to new therapies. https://hubs.ly/Q02zPRGw0 #oncology #clinicaltrials #fda
-
-
Project Farma (PF)'s Anshul Mangal sat down with Jason C. Foster of Ori Biotech to discuss unlocking scale, automation, digitalization and standardization in CGT. Listen on Spotify: https://lnkd.in/efD6iM79 Watch on Youtube: https://lnkd.in/eWtHtexx #CellTherapy #GeneTherapy #PatientAccess #Biotechnology
🎙️ Unlocking scale, automation, digitalization and standardization in CGT – with Anshul Mangal In our new Ori Spotlight podcast episode, Jason C. Foster welcomes Anshul Mangal, President at Project Farma (PF), to discuss the hurdles to scalable CGT development, and why embracing automation and digitalization can help to overcome manufacturing challenges and improve efficiencies. Together they also highlight the potential of distributed manufacturing and the critical evolution of regulatory standards. 🎧 Listen on Spotify: https://lnkd.in/efD6iM79 📺 Watch on Youtube: https://lnkd.in/eWtHtexx #ManufacturingBrighterFutures #CellTherapy #GeneTherapy #PatientAccess #Biotechnology
-
-
"We know why we get up every day and work as hard as we do. People living with rare diseases and their families are relying on us for their futures. The responsibility is awesome but the opportunity to do good is breathtaking.” - Doug Ingram, Sarepta Therapeutics With Sarepta’s groundbreaking gene therapy for Duchenne receiving accelerated approval, there is considerable interest in the insights gained from its rollout and the FDA's evolving language around complex rare disease medications. Brought to you by Precision For Medicine and hosted by Endpoints News. WATCH NOW: https://hubs.ly/Q02zttRY0 #CGTx #CGTxDay2024 #CellTherapy #GeneTherapy #transformativemedicine #raredisease
-